Bloomberg Law
March 18, 2022, 6:50 PMUpdated: March 18, 2022, 7:02 PM

Arbutus Is Sued Over Pfizer’s Covid Vaccine Delivery Tech (1)

Christopher Yasiejko
Christopher Yasiejko

The company whose delivery technology Pfizer Inc. licenses for use in its Covid-19 vaccine sued Arbutus Biopharma Corp. in Manhattan federal court Friday, seeking a judgment that the shot doesn’t infringe nine patents over which Arbutus and its partner Genevant Sciences GmbH have threatened to sue.

Acuitas Therapeutics Inc., a closely held biotech company based in Vancouver, said Arbutus and Genevant “had nothing to do with” the success of the vaccine, called Comirnaty, according to a complaint filed in the U.S. District Court for the Southern District of New York. Pfizer and BioNTech SE, which helped develop it, ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.